Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15757 articles
Diagnostic value of the combination of DAPK methylation in urinary sediment and B ultrasound for recurrent urinary bladder cancer
Results of cystoscopy showed agreement with B ultrasound.
»
08/26/23
Progranulin promoted the proliferation, metastasis, and suppressed apoptosis via JAK2-STAT3/4 signaling pathway in papillary thyroid carcinoma
PGRN overexpressed in PTC tissue and increased by 75% at mRNA level.
»
09/02/23
Angiogenesis modulated by CD93 and its natural ligands IGFBP7 and MMRN2: a new target to facilitate solid tumor therapy by vasculature normalization
Antiangiogenic therapy only benefitted a few patients and caused many side effects.
»
09/02/23
BPH-related False Positive of PSMA-PET in the Diagnosis of Prostate Cancer: the Achilles' Heel of Biopsy-free Radical Prostatectomy?
Benign prostatic hyperplasia-related false positive rate of PSMA-PET in detecting prostate cancer 30%.
»
08/30/23
Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatment.
Silencing of CDC25A in OV90 cells confers resistance to AZD6738.
»
04/16/23
Risk Factor of Sarcopenia After Gastrectomy in Elderly Patients With Gastric Cancer.
Open gastrectomy independent risk factor for progression of sarcopenia.
»
06/15/23
RYBP contributes to improved prognosis in colorectal cancer via regulation of cell cycle, apoptosis and oxaliplatin sensitivity.
Low RYBP expression significantly associated with risk of distant metastasis.
»
03/31/23
Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-up.
Multimodal glioma therapy affects neurocognition less than generally assumed.
»
07/10/23
PD-L1 protein expression by Combined Positive Score (CPS) in patients with muscle invasive or advanced urothelial carcinoma: a single institution experience
Patients with maximal CPS of 100 enriched in “basal” molecular subtype.
»
09/01/23
Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant
MONALEESA-3 reports longest mOS thus far (67.6 months) for 1L patients.
»
08/31/23
< Prev
Next >